KSKamilė Stankevičiūtė

Kamilė Stankevičiūtė

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamilė Stankevičiūtė has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MEDS — An Emerging Data Standard and Ecosystem for Health AI Research

    by Matthew B. A. McDermott, Ethan Steinberg, Jason A. Fries, Robin P. van de Water, Chao Pang, Patrick Rockenschaub, Pawel Renc, Jungwoo Oh, Kamilė Stankevičiūtė, Justin Xu, et al.


  • Open Access

    MEDS: Building Models and Tools in a Reproducible Health AI Ecosystem

    by Matthew B. A. McDermott, Justin Xu, Teya S. Bergamaschi, Hyewon Jeong, Simon A. Lee, Nassim Oufattole, Patrick Rockenschaub, Kamilė Stankevičiūtė, Ethan Steinberg, Jimeng Sun, et al.


  • Bridging the Worlds of Pharmacometrics and Machine Learning

    by Kamilė Stankevičiūtė, Jean-Baptiste Woillard, Richard W. Peck, Pierre Marquet, Mihaela van der Schaar

    Precision medicine requires individualized modeling of disease and drug dynamics, with machine learning-based computational techniques gaining increasing popularity. The complexity of either field, however, makes current pharmacological problems opaque to machine learning practitioners, and state-of-the-art machine learning methods inaccessible to pharmacometricians. To help bridge the two worlds, we provide an introduction to current problems and techniques in pharmacometrics that ranges from pharmacokinetic and pharmacodynamic modeling to pharmacometric simulations, model-informed precision dosing, and systems pharmacology, and review some of the machine learning approaches to address them. We hope this would facilitate collaboration between experts, with complementary strengths of principled pharmacometric modeling and flexibility of machine learning leading to synergistic effects in pharmacological applications.


  • Open Access

    Population Graph GNNs for Brain Age Prediction

    by Kamilė Stankevičiūtė, Tiago Azevedo, Alexander Campbell, Richard Bethlehem, Pietro Liò

    Many common neurological and neurodegenerative disorders, such as Alzheimer’s disease, dementia and multiple sclerosis, have been associated with abnormal patterns of apparent ageing of the brain. Discrepancies between the estimated brain age and the actual chronological age (brain age gaps) can be used to understand the biological pathways behind the ageing process, assess an individual’s risk for various brain disorders and identify new personalised treatment strategies. By flexibly integrating minimally preprocessed neuroimaging and non-imaging modalities into a population graph data structure, we train two types of graph neural network (GNN) architectures to predict brain age in a clinically relevant fashion as well as investigate their robustness to noisy inputs and graph sparsity. The multimodal population graph approach has the potential to learn from the entire cohort of healthy and affected subjects of both sexes at once, capturing a wide range of confounding effects and detecting variations in brain age trends between different sub-populations of subjects.